Octapharma AG
Records under this name other than the patents Octapharma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,512,457 | Serum-free stable transfection and production of recombinant human proteins in human cell lines Term ended Term ended Jun 29, 2026 · From the USPTO record | Term ended | Term ended Jun 29, 2026 | From the USPTO record |
| US 9,796,986 | Serum-free stable transfection and production of recombinant human proteins in human cell lines Term ended Ended no later than Jun 29, 2026 · From the USPTO record | Term ended | Ended no later than Jun 29, 2026 | From the USPTO record |
| US 9,943,600 | Stabilizing agent for pharmaceutical proteins Lapsed on the fee record Ended Apr 17, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2026 | From the USPTO record |
| US 7,553,938 | Method of Providing a Purified, Virus Safe Antibody Preparation Term ended Term ended Feb 25, 2025 · High confidence | Term ended | Term ended Feb 25, 2025 | High confidence |
| US 7,572,619 | Recombinant blood clotting factors Term ended Term ended Nov 17, 2024 · From the USPTO record | Term ended | Term ended Nov 17, 2024 | From the USPTO record |
| US 10,214,575 | Process for the Purification of a Growth Factor Protein Lapsed on the fee record Ended Feb 26, 2023 · High confidence | Lapsed on the fee record | Ended Feb 26, 2023 | High confidence |
| US 10,098,956 | Stabilizing agent for pharmaceutical proteins Lapsed on the fee record Ended Oct 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 16, 2022 | From the USPTO record |
| US 8,436,142 | Processing of recombinant human G-CSF precursor Lapsed on the fee record Ended May 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended May 7, 2021 | From the USPTO record |
| US 9,453,045 | Process for the Purification of a Growth Factor Protein Lapsed on the fee record Ended Sep 27, 2020 · High confidence | Lapsed on the fee record | Ended Sep 27, 2020 | High confidence |
| US 6,518,406 | Method for purification of proteins Term ended Term ended Jun 21, 2020 · From the USPTO record | Term ended | Term ended Jun 21, 2020 | From the USPTO record |